Latest article
Healio: DARE-19: Dapagliflozin well-tolerated for inpatient COVID-19 with, with out diabetes
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...
Jules Koundé scuffling with health points
" Back
The evening team report that Sevilla and...
JODY HOLTON — Kind 2 diabetes and also you, don’t miss the indicators –...
This week we will be focusing on type 2 diabetes as it is the most common...